Although transsphenoidal craniotomy (TSC) is considered the gold standard intervention for the treatment of acromegaly, it is imperative that the goal of treatment—the restoration of a normal GH secretion profile and normalization of serum IGF-1—not be overlooked [13]. The gene discussed is IGF1; the disease is acromegaly.